Lee Hyo-keun is the CEO of SD Biosensor.
He is focusing his capabilities on building distribution networks in North America.
He is also accelerating efforts to improve the company’s business structure by localizing global production bases and expanding non-COVID product lines.
He was born on October 12, 1963, in Suwon, Gyeonggi Province.
He graduated from Yushin High School in Gyeonggi and earned a degree in chemical engineering from Ajou University.
He worked at Yuhan Cyanamid for 10 years. He later moved to SD (now Abbott Diagnostics Korea), where he served as executive vice president in charge of the glucose business division.
In 2010, he was appointed CEO of SD Biosensor.
He is an expert in the in vitro diagnostics field.
During the COVID-19 pandemic, he increased SD Biosensor’s revenue to nearly KRW 3 trillion (US$ 2.2 billion) by expanding the company’s share in overseas markets.
#SDBiosensor #LeeHyoKeun #diagnostics #COVID19 #globalexpansion #NorthAmerica #biotech #healthcare #IVD #KoreaBusiness